期刊文献+

孤独症儿童及期I级亲属血浆五羟色胺水平的对照研究 被引量:1

A control study on plasma serotonin in autistic probands and their first degree relatives
原文传递
导出
摘要 目的通过测定儿童孤独症核心家系五羟色胺(5-HT)水平,探讨孤独症先证者及其I级亲属的5-HT水平的家族聚集性特征。方法采用高效液相色谱仪测定儿童孤独症组(38例)及其亲生父母组(61例)的5-HT水平,并与年龄和性别相匹配的正常儿童对照组(35例)及正常成人对照组(60例)的5-HT水平相比较。结果①儿童孤独症组的血浆5-HT水平为(212.51±127.98)μmol/L,显著高于正常儿童对照组(t=3.842,P=0.000);②孤独症父母组的血浆5-HT水平为(88.15±48.15)μmol/L,显著高于正常成人对照组(t=3.409,P=0.001)。③儿童孤独症的病情严重程度与血浆5-HT水平两者之间无显著相关(r=0.142,P=0.041)。④孤独症儿童组的血浆5-HT水平与孤独症儿童的父亲和母亲的血浆5-HT水平两者之间均存在显著相关(r=-0.498,P:0.000;r=-0.602,P=0.000)。结论儿童孤独症血浆5-HT增高并与遗传因素相关,可作为中间表型为孤独症遗传易感因子的研究提供线索。 Objective To investigate the familial aggregation of 5-HT level in parents of autistic probands. Methods In a sample of 38 autistic subjects and 61 of their parents,compared to age and sex matched controls. 5-HT were measured by HPLC. Results The level of 5-HT in autistic children was significant higher than the controls subjects( t =3. 842, P = 0. 000). The significant difference of 5-HT level between autism children parents and normal children parents was found( t = -3. 409, P=O. 001 ). The severity degree of autism was not significant related to the 5-HT level( r=0. 142, P=O. 041 ). The 5-HT level of autistic children was significant related to the 5-HT level of their parents ( r = - 0. 498, P = 0. 000 ; r = - 0. 602, P = 0. 000 ). Conclusion Elevated 5-HT level may be associated with genetic liability to autism and help the search of genetic susceptibility factors in autism.
机构地区 深圳市康宁医院
出处 《中国行为医学科学》 CSCD 2008年第7期617-618,共2页 Chinese Journal of Behavioral Medical Science
关键词 5-HT 儿童孤独症 家族聚集性 遗传 Serotonin Autism Familial aggregation Genetic
  • 相关文献

参考文献11

  • 1Marion L,Anne P,Manuel B,et al. Whole Blood Serotonin and. Plasma Beta-Endorphin in Autistic Probands and Their First-Degree Relatives. Biol Psychiatry, 1999,45 : 158-163. 被引量:1
  • 2Piven J,Tsai GC, Nehme E, et al. Platelet serotonin, a possible marker for familial autism. J Autism Dev Disorder, 1991,21:51-59. 被引量:1
  • 3Diane C, Chugani,Otto Muzik, et al. Developmental Changes in Brain Serotonin Synthesis Capacity in Autistic and Nonautistic Children. Annals of Neurology, 1999:22-25. 被引量:1
  • 4张作记.儿童孤独症评定量表.见:中国行为医学科学编辑委员会编.行为医学量表手册.北京:中华医学电子音像出版社,2005:476-477. 被引量:2
  • 5Bailey A,Couteur LA, Gottesman I, et al. Autism as a strongly genetic disorder:Evidence from a British twin study. Psychological Medicine, 1995,25:63-77. 被引量:1
  • 6Folstein SE, Piven J. Etiolgy of autism: genetic influences. Pediatrics, 1991,87:767-773. 被引量:1
  • 7Rutter M,Taylor E, Hersov L. Child and adolescent Psychiatry: modem approaches. 3rd edition. Oxford : Blackwell Scientific, 1994:569-594. 被引量:1
  • 8Murphy M, Bohon PF, Pickles A, et al. Personality traits of the relatives of autistic probands. Psychological Medicine ,2000,30:1411-1424. 被引量:1
  • 9Anne Mcbride P, George M. Effects of Diagnosis, Race, and Puberty on Platelet Serotonin Levels in Autism and Mental Retardation. J Am Aead Child Adolesc Psychiatry, 1998,37:7. 被引量:1
  • 10焦公凯,王伟勇,张志珺,方群,邹冰,王晨阳,金利波,柯晓燕,王民洁,林节.儿童孤独症血浆5-羟色胺水平的对照研究[J].临床精神医学杂志,2003,13(6):334-335. 被引量:8

二级参考文献15

  • 1马宁,谭立文,李凌江,李功迎,余邦宁.不同强迫症状的临床特点及与5-HT2A/T102C多态性的关系[J].中国行为医学科学,2005,14(10):908-910. 被引量:3
  • 2任显峰,张宪香.氟西汀合并认知行为疗法治疗强迫症的对照研究[J].中国行为医学科学,2006,15(5):450-450. 被引量:7
  • 3韩济生 主编.神经生物学纲要[M].北京:北京医科大学中国协和医科大学联合出版社,1993.383-397. 被引量:1
  • 4Barr LC, Goodman WK, Price LH, et al. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacolo- gic challenge studies. J Clin , 1992,53 : 17-28. 被引量:1
  • 5Horvath S, Laird NM, Knapp M. The transmission disequilibrium test and parentalgenotype reconstruction for X-chromosomal markers. Am J Hum Genet,2000,66 : 1161-1167. 被引量:1
  • 6Enoch MA, Greenberg BD, Murphy DL, et al. Sexually dimorphic relationship of 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biol Psychiatry,2001,49:385. 被引量:1
  • 7Walitza S, Wewetzer C, Wamke A, et al. 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorder. Mol Psychiatry,2002,7 : 1054-1057. 被引量:1
  • 8Tot S, Erdal ME, Yazici K, et al. T102C and-1438G/A polymorphisms of the 5-HT2A receptor gene in Turkish patients with obsessive-compulsive disorder . Eur Psychiatry,2003,18:249-254. 被引量:1
  • 9Nicolini H, Cruz C, Camarena B, et al. DRD2,DRD3 and 5-HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychitry,1996,1161:461. 被引量:1
  • 10Frisch A, Michaelovsky E, Rockah R, et al. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonetic and dopaminergic pathways. Eur Neuropsychopharmacol,2000,10 : 205. 被引量:1

共引文献13

同被引文献11

  • 1H6rauh J, Petit E, Martineau J, et al. Serotonin and autism: biochemical and molecular biology features. Psychiatry Re- search, 1996, 1 (65): 33-43. 被引量:1
  • 2Potenza MN, Holmes JP, Kanes SJ, et al. Olanzapine treat-ment of children, adolescents, and adults with pervasive de- velopmental disorders: an open-label pilot study. J Clin Psy- chopharmacol, 1999, 19 (1): 37-44. 被引量:1
  • 3Hollander E, Wasserman S, Swanson EN, et al. A double- blind placebo-controlled pilot study of olanzapine in child- hood/adolescent pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology, 2006, 16 (5) : 541-548. 被引量:1
  • 4Kemner C, Willemsen- Swinkels SHN, de Jonge M, et al. Open-label study of olanzapine in children with pervasive de- velopmental disorder. J Clin Psychopharmacol, 2002, 22 (5) : 455-460. 被引量:1
  • 5Fido A, A1-Saad S. Olanzapine in the treatment of behavioral problems associated with autism: an open-label trial in Ku- wait. Med Pfinc Pract. 2008, 17 (5) : 415-418. 被引量:1
  • 6Kirino E. Efficacy and tolerability of pharmaeotherapy options for the treatment of irritability in autistic children. Clin Med Insights Pediatr. 2014, 8: 17-30. 被引量:1
  • 7Malone RP, Cater J, Sheikh RM, et al. Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. J Am Aead Child Adolesc Psychiatry, 2001, 40 (8) : 887-894. 被引量:1
  • 8Politte LC, Mcdougle CJ. Atypical antipsyehoties in the treatment of children and adoleseents with pervasive develop- mental disorders. Psychopharmaeology ( Berl), 2014, 231 (6) : 1023-1036. 被引量:1
  • 9李雪蓉,康传媛.孤独症异常行为问题的精神药物治疗进展[J].国际精神病学杂志,2013,40(3):179-182. 被引量:2
  • 10盛娟,钦松,郭伟,张新风.孤独症谱系障碍病因、诊断、治疗的研究进展[J].国际精神病学杂志,2014,41(1):32-34. 被引量:23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部